Therapy of chronic hepatitis b with recombinant human alpha and gamma interferon

Adrian M. Di Bisceglie, Vinod K. Rustgi, Chris Kassianides, Mauricio Lisker‐Melman, Yoon Park, Jeanne G. Waggoner, Jay H. Hoofnagle

Research output: Contribution to journalArticlepeer-review

50 Scopus citations


Eight patients with chronic hepatitis B entered a pilot study of gamma interferon and alpha interferon in combination. Gamma interferon alone had minimal inhibitory effects on serum levels of hepatitis B virus as monitored by serum HBV DNA and DNA‐polymerase activity. The drug also gave troublesome side effects. In contrast, alpha interferon had more potent inhibitory effects on serum HBV levels and fewer side effects. When combined, the two interferons showed no additive or synergistic effects in inhibiting serum levels of HBV DNA or DNA polymerase. These findings indicate that the addition of gamma interferon to alpha interferon provides no additional antiviral effects but contributes significantly to side effects.

Original languageEnglish
Pages (from-to)266-270
Number of pages5
Issue number2
StatePublished - Feb 1990


Dive into the research topics of 'Therapy of chronic hepatitis b with recombinant human alpha and gamma interferon'. Together they form a unique fingerprint.

Cite this